Healthcare Industry News:  Pulse Oximetry 

Devices Monitoring

 News Release - January 31, 2007

Philips Introduces First Spot Check Monitor with Large 8.4'' Color LCD Display, Allowing Clinicians to Focus More on Patient Care and Safety

Advanced, versatile design meets growing demand for high-quality patient care at an affordable price

ANDOVER, Mass.--(HSMN NewsFeed)--Royal Philips Electronics (NYSE: PHG, AEX: PHI) today announced the release of its new vital signs monitor, the Philips SureSigns VS3. Unlike traditional spot-check monitors, the SureSigns VS3 has a large 8.4" color LCD display and a simple user interface to make it easier for clinicians to assess patient vital signs information. Designed for use both in and out of the hospital, the SureSigns VS3 is suitable for general care wards, emergency departments, outpatient surgery and urgent care centers. The advanced, versatile design of the Philips SureSigns VS3 allows clinicians to work more efficiently while providing quality patient care and safety.

"Every day, healthcare providers are faced with high patient volume, limited staff and the need to make decisions quickly," said Bill Putnam, general manager of low acuity patient monitoring for Philips Medical Systems. "Clinicians need a simple monitoring solution that will allow them to easily view basic patient status and capture relevant data. The efficient and innovative design of the SureSigns VS3 sets the standard for basic vital signs monitoring. Now clinicians can have a clear view of patient information so they can focus on providing the best quality of care at an affordable price."

The SureSigns VS3 provides easy access to patient information using innovative pop-up screens, fixed keys and icon-based menus. The full-color, back-lit screen displays large, easy-to-read numerals that are especially helpful when viewing from a distance or in low light situations. The screen also provides clinicians with the choice of viewing scrollable stored patient records and an optional Sp02 waveform. SureSigns VS3 measurements include non-invasive blood pressure, Pulse Oximetry, pulse rate and temperature. With programmable non-invasive blood pressure capabilities, users can create up to five different programs to monitor non-invasive blood pressure at particular intervals based on unit-specific protocols.

The SureSigns VS3's standard lithium ion battery and AC power cord clip enhance battery operation and charging performance. Software upgrades are remarkably quick and easy via the USB port and patient data transfer is enabled with HL7 data output through an Ethernet connection. In addition, an optional bar code scanner capable of reading both one and two-dimensional bar codes makes patient ID entry fast and accurate. The innovative design also makes the SureSigns VS3 monitor easy to support. Replacement parts are compatible with the SureSigns VM monitors to help streamline parts inventory management and repair.

For more information about the SureSigns VS3 vital signs monitor go to

About Royal Philips Electronics

Royal Philips Electronics of the Netherlands (NYSE: PHG, AEX: PHI) is a global leader in healthcare, lifestyle and technology, delivering products, services and solutions through the brand promise of "sense and simplicity." Headquartered in the Netherlands, Philips employs approximately 121,700 employees in more than 60 countries worldwide. With sales of USD 34 billion (EUR 27 billion) in 2006, the company is a market leader in medical diagnostic imaging and patient monitoring systems, energy efficient lighting solutions, personal care and home appliances, as well as consumer electronics. News from Philips is located at

Source: Royal Philips Electronics

Issuer of this News Release is solely responsible for its content.
Please address inquiries directly to the issuing company.

FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.